Purified Human IgA1

<strong>Purified Human IgA1 </strong>_x000D_ <strong>Catalog number:</strong> B2011207_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1.0 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> &gt; 1.0 mg/mL_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8 °C_x000D_ <strong>Keywords:</strong> Human IgA1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Iwase H, Ishii-Karakasa I, Fujii E, Hotta K, Hiki Y, Kobayashi Y. Analysis of glycoform of O-glycan from human myeloma immunoglobulin A1 by gas-phase hydrazinolysis following pyridylamination of oligosaccharides Anal Biochem. 1992 Oct;206(1):202-5._x000D_ 2: Sandler SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions Transfus Med Rev. 1995 Jan;9(1):1-8._x000D_ 3: Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1 Contrib Nephrol. 2007;157:129-33._x000D_ 4: Spiegelberg HL, Fishkin BG. Human myeloma IgA half-molecules J Clin Invest. 1976 Nov;58(5):1259-65._x000D_ 5: Takahashi K, Raska M, Stuchlova Horynova M, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, Renfrow MB, Novak J. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy PLoS One. 2014 Jun 11;9(2):e99026._x000D_ 6: Moore JS, Kulhavy R, Tomana M, Moldoveanu Z, Suzuki H, Brown R, Hall S, Kilian M, Poulsen K, Mestecky J, Julian BA, Novak J. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins Mol Immunol. 2007 Apr;44(10):2598-604._x000D_ 7: Renfrow MB, Mackay CL, Chalmers MJ, Julian BA, Mestecky J, Kilian M, Poulsen K, Emmett MR, Marshall AG, Novak J. Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy Anal Bioanal Chem. 2007 Nov;389(5):1397-407._x000D_ 8: Camilla R, Suzuki H, Daprà V, Loiacono E, Peruzzi L, Amore A, Ghiggeri GM, Mazzucco G, Scolari F, Gharavi AG, Appel GB, Troyanov S, Novak J, Julian BA, Coppo R. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy Clin J Am Soc Nephrol. 2011 Aug;6(8):1903-11._x000D_ 9: Lugassy G, Platok I, Schlesinger M. Hypocomplementemia in multiple myeloma Leuk Lymphoma. 1999 Apr;33(3-4):365-70._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/27841786">10: Enders P, Holtick U, Schaub F, Tuchscherer A, Hermann MM, Scheid C, Cursiefen C, Bachmann BO. Corneal Densitometry for Quantification of Corneal Deposits in Monoclonal Gammopathies Cornea. 2017 Apr;36(4):470-475. </a>_x000D_ _x000D_ <strong>Products Related to Purified Human IgA1 can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>